Titlebook: Hematopoietic Growth Factors in Oncology; Basic Science and Cl George Morstyn,MaryAnn Foote,Graham J. Lieschke Book 2004 Springer Science+B

Fibromyalgia

書目名稱Hematopoietic Growth Factors in Oncology影響因子(影響力)




書目名稱Hematopoietic Growth Factors in Oncology影響因子(影響力)學(xué)科排名




書目名稱Hematopoietic Growth Factors in Oncology網(wǎng)絡(luò)公開度




書目名稱Hematopoietic Growth Factors in Oncology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Hematopoietic Growth Factors in Oncology被引頻次




書目名稱Hematopoietic Growth Factors in Oncology被引頻次學(xué)科排名




書目名稱Hematopoietic Growth Factors in Oncology年度引用




書目名稱Hematopoietic Growth Factors in Oncology年度引用學(xué)科排名




書目名稱Hematopoietic Growth Factors in Oncology讀者反饋




書目名稱Hematopoietic Growth Factors in Oncology讀者反饋學(xué)科排名

陳舊

George Morstyn MBBS, PhD, FRACP,MaryAnn Foote PhDly nonlinear system. Finally, we evaluate the underlying mechanisms, such as the dependence upon the axonal delays, the local inhibition, structural feedback, and discuss applications to associative feature linking, pattern segmentation, and context-sensitive binding.

VICT

特別容易碎

committed

David J. Kuter MD DPhiltals of electric circuits and develops circuit theorems. It is useful to engineers, researchers and graduate students who are interested in the basic electric circuit theory and the regulation and monitoring of power supply systems.

Coma704

解脫

Commentary on the ASCO and ESMO Evidence-Based Clinical Practice Guidelines for the Use of Hematopoiinical Oncology (ASCO) to publish its first clinical practice guidelines in 1994 .. These guidelines were updated in 1996 . and in 2000 (1). The European Society for Medical Oncology (ESMO) recommendations for the use of these hematopoietic growth factors (HGFs) appeared in 2001 ..

難解

Petechiae

名詞

Thrombocytopenia and Platelet Transfusions in Patients With Cancerubstantially, from 365,000 units in 1989 to 1,264,000 units in 2001 (Table 1) .. This increase is being driven partly by the need for alternative platelet inventories to support cardiac surgery, oncology, and peripheral blood progenitor cell (PBPC) transplantation programs and partly by use of leukoreduced platelet products ..